Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • HealthTech Dialogues
    • CureFit Healthcare...

    CureFit Healthcare Raised Rs 19.2 Cr from Ratan Tata, University of California

    Written by savita thakur thakur Published On 2017-05-09T15:59:54+05:30  |  Updated On 9 May 2017 3:59 PM IST

    CureFit Healthcare Pvt Ltd has raised 3 million dollars (Rs 19.2 crore) in a fresh round of funding from UC-RNT Fund, a joint venture between Ratan Tata’s RNT Associates and the University of California.


    CureFit is a Bengaluru based company, the company operates a platform which enables users to manage their health proactively through a range of service offerings.


    Along with the RNT Associates and the University of California other investors include Gokul Rajaram, product engineering lead at US-based mobile point of sale provider Square; Aditya Agarwal and Ruchi Sanghvi, vice presidents of engineering and operations, respectively, at file sharing application firm Dropbox; and Shishir Mehrotra, former vice president of product, engineering and UX at YouTube also invested in the CureFit.


    With this round of funding, the company will take its total capital raised to $18 million.


    Speaking about the funding, Mukesh Bansal co-founder of CureFit explained, “The funding happened a while back and it is not only about UC-RNT as Tata has also invested in his personal capacity. Besides, prominent Silicon Valley tech leaders have also invested in CureFit. This is more about the caliber of people that the company can get associated with."


    "We are offering an integrated solution to users in three areas -fitness, food and mental health. We started off with our fitness offering of Cult, which now has 5,000 paid subscribers," Bansal said.


    Meanwhile talking about the mobile app Cult.fit Bansal explained, “While some of the DIY (do it yourself) videos on working out from home in cult.fit will be free of cost, users will have to subscribe and pay offline for the 10 Cult fitness centres in Bangalore. Likewise, the health recipes on eat.fit are free, while users will have to pay for health foods available on its platform. The entire section of the mental health platform, which is mostly DIY videos on meditation, is also available free of coast to users,"


    "The users can also book workout classes at Cult centres and order healthy Indian and fusion food in Bengaluru," cure.fit said.


    "Health is going to be $500 billion industry in India by 2025. There is an opportunity to build next generation health platform to service hundreds of millions of Indians who cannot be serviced through traditional channels," said Mukesh Bansal, Co-founder, cure.fit.


    "We are pioneering a novel approach to build one stop shop for all health needs and enable long term good health."

    CultfitcurefitCureFit Healthafitness appInvestmentmobile appMukesh BansalRatan TataUC-RNT FundUniversity of California

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok